DR.Chip Biotechnology Incorporation reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 18.4 million compared to TWD 25.86 million a year ago. Revenue was TWD 18.4 million compared to TWD 25.86 million a year ago. Net loss was TWD 4.44 million compared to TWD 4.7 million a year ago. Basic loss per share from continuing operations was TWD 0.2288 compared to TWD 0.2288 a year ago. Diluted loss per share from continuing operations was TWD 0.2288 compared to TWD 0.2288 a year ago. For the nine months, sales was TWD 62.67 million compared to TWD 69.61 million a year ago. Revenue was TWD 62.67 million compared to TWD 69.61 million a year ago. Net loss was TWD 10.63 million compared to TWD 19.97 million a year ago. Basic loss per share from continuing operations was TWD 0.5592 compared to TWD 1.0421 a year ago. Diluted loss per share from continuing operations was TWD 0.5592 compared to TWD 1.0421 a year ago.